Introduction to the efficacy and effects of dacomitinib

Dacomitinib, a cancer drug designed for adults with advanced or metastatic non-small cell lung cancer (NSCLC), has shown strong therapeutic potential by targeting specific genetic mutations. In the field of NSCLC, this disease accounts for the vast majority of lung cancer cases, and late diagnosis is often accompanied by high metastasis and low survival rates, posing great challenges to treatment. It is particularly worth noting that mutations in the EGFR gene are extremely common in NSCLC and are closely related to lymph node metastasis and poor sensitivity to chemotherapy, making treatment strategies targeting EGFR particularly important.

Dacomitinib emerged based on this background. It belongs to the tyrosine kinase inhibitor class of drugs and can accurately block EGFR activity. EGFR, as a key protein that controls cell growth and division, is often overactive in lung cancer cells, thereby driving the uncontrolled growth of cancer cells. Through its unique inhibitory effect, dacomitinib can effectively slow down the growth and spread of cancer, bringing patients longer survival and better quality of life.

Especially for those patients with specific mutations in the EGFR protein gene, the therapeutic effect of dacomitinib is particularly significant. Not only can it be used alone, it also shows good safety and tolerability, allowing patients to maintain good physical condition during treatment. Therefore, dacomitinib not only provides a new option for the treatment of NSCLC, but also brings new hope to patients for whom traditional treatments are ineffective.

The original drug dacomitinib has been launched in my country and is eligible for medical insurance reimbursement. Please consult the medical insurance reimbursement department for the reimbursement ratio. SpecificationsA drug of 15 mg and 30 tablets costs about more than 1,000 yuan after reimbursement. In addition, there are also generic versions of this drug in Laos. The price is 30 tablets of 45 mg. A box of Element Pharmaceuticals is about 1,500 yuan, and a box of Lucius Pharmaceuticals is about 1,200 yuan. Regarding the price of dacomitinib, it is recommended to consult a professional overseas medical consulting company.